Russell Rosenberg, MD
Interventional Cardiology · Philadelphia, PANPI 1750795175
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (38.9%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Neptune Medical Inc. at 27.4% of the total. Reporting peaked in 2024 at $3,508 and has fallen 88.7% since, to $395 in 2025.
Across 101 payments — averaging $92.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neptune Medical Inc.$3K
- Medtronic$2K
- Philips North America LLC$1K
- Veryan Medical Incorporated$915
- Boston Scientific$639
- Cook Medical LLC$330
- plus $1K from 12 others
Across 25 payments — averaging $3222.71 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Janssen Research & Development, LLC$48K
- Harmony Biosciences LLC$29K
- Idorsia Pharmaceuticals US Inc$3K
What the payments were for
- Consulting fees$3,52738%
- Grants$5366%
- Travel & lodging$1,45816%
- Food & beverage$3,62539%
- Education$1712%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neptune Medical Inc. | 2 | $2,554 |
| Medtronic(2 entities) | 44 | $2,126 |
| Philips North America LLC | 2 | $1,318 |
| Veryan Medical Incorporated | 4 | $915 |
| Boston Scientific | 7 | $639 |
| Cook Medical LLC | 7 | $330 |
| Inari Medical, Inc. | 4 | $305 |
| Abiomed | 9 | $214 |
| W. L. Gore & Associates, Inc. | 5 | $202 |
| Bard Peripheral Vascular, Inc. | 3 | $197 |
| Cardiovascular Systems Inc. | 2 | $129 |
| Shockwave Medical, Inc | 5 | $120 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $75 |
| Imperative Care, Inc | 1 | $64 |
| Cathworks, Inc. | 1 | $43 |
| Johnson & Johnson | 2 | $36 |
| Stryker | 1 | $29 |
| Endovascular Engineering Inc. | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,317 in reported general payments places this provider in the 60th percentile of 281 interventional cardiology providers in Pennsylvania.
See all interventional cardiology providers in Pennsylvania →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 22 | $23,687 |
| FarxigaDapagliflozin Propanediol | 14 | $8,974 |
| Colchicine | 12 | $1,505 |
| Atorvastatin Calcium | 47 | $1,115 |
| Rosuvastatin Calcium | 45 | $957 |
| Ezetimibe | 23 | $663 |
| ClopidogrelClopidogrel Bisulfate | 31 | $661 |
| Valsartan | 15 | $540 |
| Metoprolol Succinate | 36 | $510 |
| Lisinopril | 31 | $346 |
| Carvedilol | 28 | $291 |
| Amlodipine Besylate | 36 | $229 |
| Losartan Potassium | 14 | $156 |
| Furosemide | 24 | $130 |
| Hydrochlorothiazide | 20 | $74 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Philadelphia
- Jon GeorgePhiladelphia$637K
- Sanjog KalraPhiladelphia$444K
- Taisei KobayashiPhiladelphia$384K
- Howard HerrmannPhiladelphia$259K
- Jay GiriPhiladelphia$157K
- Paul FiorilliPhiladelphia$104K
- Nicholas RuggieroPhiladelphia$74K
- Craig FrankilPhiladelphia$59K
- Michael BodePhiladelphia$58K
- Oleg VishnevskyPhiladelphia$49K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.